Quick Answer
It depends on what the patch contains and what the box claims. A plain hydrocolloid patch that absorbs fluid from a blemish sits in FDA's device database as a class I wound dressing. Add salicylic acid and an acne claim, and it becomes an OTC acne drug. Microneedle patches are a gray zone that needs a regulatory answer before you place an order.
Pimple patches look like the simplest product in K-beauty: a few clear dots in a small tin. The rules behind them are not simple. The same dot can be a cosmetic, a medical device or an OTC drug in the US, depending on what is in it and what the box says.
This guide compares the three patch types founders usually ask Korean factories for, then covers what each route needs from your manufacturer, your label and your claims.
Key Takeaways
- Intended use decides the category, and your claims set the intended use.
- Hydrocolloid acne patches are listed by FDA under product code NAD, a class I occlusive wound dressing that is exempt from 510(k).
- A salicylic acid patch that claims to treat acne follows the OTC acne monograph: Drug Facts, drug registration and drug manufacturing rules.
- Microneedle patches fall under FDA's microneedling guidance, and needles that carry an active raise a combination product question.
- In Korea, the acne functional cosmetic category is limited to wash-off products, so a leave-on patch cannot use it.
Is a Pimple Patch a Cosmetic, a Medical Device or a Drug?
A pimple patch is whatever its intended use makes it. FDA says intended use decides whether a product is a cosmetic or a drug. Claims on the label, in ads and online are the first way that intended use is set (FDA).
A medical device is defined by section 201(h) of the FD&C Act. It covers articles intended to treat or mitigate a condition, or to affect the body's structure or function. A device does not achieve its main purpose through chemical action (FDA). A hydrocolloid patch is a thin adhesive dressing that turns fluid into a soft gel, so a patch that covers a broken blemish and absorbs fluid fits that description. A drug works through chemical action, which is why an acne active changes the category.
So the first decision is not which factory to use. It is which patch you are making and which sentence goes on the box.
Three Patch Types, Three US Rule Sets
Most patch briefs fall into three types, and each one points to a different part of FDA. The table shows where each type lands when the claims match the product.
| Patch type | US category | What FDA expects | Claims that fit |
|---|---|---|---|
| Plain hydrocolloid dot, no active | Medical device: occlusive wound dressing, product code NAD, class I | Device establishment registration and listing, quality system rules, device labeling | Covers a blemish, absorbs fluid, protects the spot |
| Hydrocolloid dot with salicylic acid | OTC acne drug under monograph M006 | Drug establishment registration, drug listing, Drug Facts panel, drug manufacturing rules | Acne treatment wording allowed by the monograph |
| Dissolving microneedle patch | Gray zone: device, or a combination product when it carries an active | A device determination before launch, under FDA's microneedling guidance | Settle the route with a regulatory consultant first |
| Patch with botanicals only, such as tea tree or centella | Cosmetic, while the claims stay cosmetic | Cosmetic rules, including MoCRA registration and listing | Covers and conceals, soothes the look of skin |
Botanical patches are the common trap. Tea tree oil and centella are not actives in the US acne monograph (FDA M006). An acne-treatment claim on them points to an unapproved drug, not a cosmetic.
What Does FDA Require for a Plain Hydrocolloid Patch?
A plain hydrocolloid acne patch is regulated as a class I medical device when its claims match a dressing, and it does not need a 510(k) before sale. Product code NAD is the FDA code for occlusive wound dressings under 21 CFR 878.4020, and FDA's classification database lists it as class I and 510(k) exempt (FDA).
Hydrocolloid acne patches already appear under that code in the federal device identifier database (AccessGUDID). Exempt does not mean unregulated. The same FDA classification page says makers of exempt class I devices still have to register their establishment, and it marks this code as not exempt from good manufacturing practice.
- Registration and listing every year. A foreign factory also names a US agent (FDA).
- A device quality system. FDA's device quality rule in 21 CFR 820 incorporates ISO 13485:2016 since February 2, 2026 (FDA).
- Device labeling. The box follows device labeling rules, not the cosmetic label format or a Drug Facts panel.
- No MoCRA cosmetic listing. Cosmetic facility registration and product listing cover cosmetics, not devices.
The practical question for a Korean factory is short: does it already make this exact patch as a device for the US? Ask for its FDA establishment registration and the device listing for the product you are buying.
Salicylic Acid Patches Follow the OTC Acne Drug Rules
A patch that contains salicylic acid and claims to treat acne is an OTC drug. FDA's acne monograph, M006, sets the permitted actives, strengths and label wording, and its history page traces the rule back to the 1991 final monograph (FDA).
That puts the patch on the drug track. Drug firms register their establishments and list each drug. OTC drugs carry a Drug Facts panel under 21 CFR 201.66, and drug manufacturing follows 21 CFR parts 210 and 211 (FDA). The factory needs drug manufacturing for the active, not only a clean cosmetic line.
A product that joins a drug and a device can also be a combination product, and FDA's lead center depends on the product's primary mode of action (FDA). Confirm the route in writing before you commission artwork. The wider steps for salicylic acid products, from monograph checks to Drug Facts, are in our guide to salicylic acid acne products made in Korea.
"I'm Liz, I run ALTAMEET from Manhattan, NYC. With patches, the sentence on the box decides which kind of factory you need, so I write the claim before I shortlist a single maker. If you want a quick gut-check on whether Korean ODM fits your project, I'll give you 15 minutes free."
Where Do Microneedle Patches Fit?
Microneedle patches are the hardest call. FDA's 2020 microneedling guidance explains when a microneedling product is a device. The key test is whether the needles reach past the outer dead layer of skin into living layers (FDA).
Needles that carry an active add a second question. The guidance leaves microneedling combination products outside its scope and sends those sponsors to FDA's Office of Combination Products.
If you want a dissolving microneedle patch, ask the factory for its needle design data and its Korean status. Take that file to a US regulatory consultant before you order. FDA also takes formal classification questions through a 513(g) request (FDA). Spicule serums raise a similar line-drawing question in liquid form, covered in our spicule spec sheet guide.
Korea Draws the Acne Line Differently
Korea does not let a leave-on patch use the acne functional cosmetic category. MFDS limits the functional cosmetic for helping relieve acne-prone skin to wash-off products, such as foam cleansers, body cleansers and liquid soap (Korea.kr).
MFDS also reminds consumers that acne cosmetics are not treatments and warns about cosmetics advertised as curing or relieving acne (MFDS). An ordinary cosmetic can say it suits acne-prone skin only when it has supporting data.
A Korean patch maker may hold a cosmetic, quasi-drug or medical device license for a given patch, and the same-looking dot can sit under a different license at each maker. Ask which license covers your exact patch in Korea.
None of this transfers to the US. A Korean device license or cosmetic report registers nothing with FDA, and FDA classifies the product on its own terms. Claims such as "for acne-prone skin" also need their own test data in each market, as our non-comedogenic testing guide explains.
Which Claims Move a Patch Into Another Category?
Treatment and healing claims move a patch out of the cosmetic category. FDA names claims on the label, in advertising and online as ways intended use is set. One sentence on a marketplace listing can change the rules that apply (FDA).
| Claim on the box or listing | Where it points in the US |
|---|---|
| Covers and conceals blemishes | Cosmetic use: altering the appearance |
| Absorbs fluid from a popped pimple | Wound dressing use: medical device |
| Helps blemishes heal faster | Medical device: treating a condition |
| Treats acne or clears pimples | Drug: needs a monograph active or an approved application |
| Soothes the look of redness | Cosmetic, when no treatment claim sits next to it |
| Delivers actives into the skin with micro-needles | Microneedling device or combination product |
Drug claims on products shipped as cosmetics are also an import problem at the US border. See why FDA detains Korea-made cosmetics for the import alerts that cover drug claims.
Seven Questions for Your Korean Patch Manufacturer
Ask these before you sign a purchase order. The answers show whether the factory can supply the route your claims need.
- Which US category is this exact patch made and sold under today: cosmetic, device or OTC drug?
- For a device, what is your FDA establishment registration, and is this patch listed under product code NAD?
- Which quality system certificate covers the patch line, such as ISO 13485, and when was the last audit?
- For salicylic acid, is your site registered with FDA as a drug establishment, and who will be the labeler on the drug listing?
- Which Korean license covers the patch: cosmetic, quasi-drug or medical device?
- What skin safety data exists for the adhesive and the hydrocolloid, such as irritation or sensitization tests? Our guide to HRIPT and clinical testing covers what each test supports.
- Will you supply a label draft that matches the route, with Drug Facts for a drug or device labeling for a dressing?
For the full import picture across product types, start with our FDA guide to importing Korean skincare. New to Korean manufacturing? Our step-by-step guide to starting a K-beauty skincare brand covers the earlier decisions.
Pimple Patch Route Checklist
Walk through this checklist for your own patch line on a free 15-minute call.
Frequently Asked Questions
Do I need a 510(k) to sell hydrocolloid pimple patches in the US?
Not for a patch that fits FDA's class I occlusive wound dressing code, which FDA lists as 510(k) exempt. You still need establishment registration, device listing, a compliant quality system and device labeling. A dressing with an added drug does not stay on that simple path.
Can I list a pimple patch in FDA's cosmetic product listing under MoCRA?
Only if the patch is a cosmetic. MoCRA registration and listing cover cosmetic facilities and cosmetic products. A patch sold as a device goes through device registration and listing, and a patch sold as an OTC drug goes through drug registration and listing.
Can a tea tree or centella patch say it treats acne?
Not as a cosmetic. Tea tree oil and centella are not actives in FDA's OTC acne monograph, so an acne-treatment claim on them points to an unapproved drug. Keep the claims cosmetic or build the patch around a monograph active such as salicylic acid.
Does a Korean medical device license let me sell the same patch in the US?
No. A Korean license or cosmetic report registers nothing with FDA. The US category follows FDA's own definitions and your US claims, so confirm the US route separately before you order.
By Liz Song, K-beauty sourcing consultant.